+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 85Years
All Genders
Healthy Volunteers
ID07546760

Investigating the Effects of Liver Impairment on AZD9550 and AZD6234 Safety, Tolerability, and Pharmacokinetics in Adults

Led by AstraZeneca · Updated on 2026-10-22

28

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how the liver condition called hepatic impairment affects the way two drugs, AZD9550 and AZD6234, behave in the body. This Phase I, open-label study focuses on safety, tolerability, and how the body processes these drugs in people with severe or moderate liver impairment compared to healthy individuals with normal liver function. The study classifies participants based on Child-Pugh scores to assess the severity of liver impairment. Participants receive a single subcutaneous under the skin dose of AZD9550 first, followed by AZD6234 after a washout period to reduce any drug interaction effects. The study includes groups with severe hepatic impairment Child-Pugh Class C, moderate hepatic impairment Class B, and matched healthy controls. The drugs are administered separately during two study periods to evaluate their individual effects. During the study, participants undergo screening and receive the study drugs with monitoring for safety, immune response, and drug levels over 56 days. Assessments include blood tests, physical exams, and vital sign monitoring to track pharmacokinetics and any adverse effects. Researchers measure drug exposure AUCinf, AUClast, Cmax and secondary parameters like half-life and clearance. The study lasts until the primary completion date with ongoing safety and tolerability evaluation.

CONDITIONS

Brief Title

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here